Vaccine against COVID-19
BBV152 ▸ Facts ▸ Comments ▸ News ▸ Videos
1710 doses of COVID vaccine stolen in Haryana's Jind
Credit: ANI Duration: 03:27Published
Thiruvananthapuram hospital runs out of Covishield vaccine
Credit: ANI Duration: 01:35Published
COVID: Vaccine shortage at Mumbai's BKC Jumbo Centre
Credit: ANI Duration: 02:02Published
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin
Credit: ANI Duration: 01:14Published
320 COVAXIN doses go 'missing' from Jaipur hospital
Credit: ANI Duration: 01:49Published
320 doses of Covaxin go 'missing' from Jaipur hospital, police register case
Credit: HT Digital Content Duration: 01:53Published
Kerala dance trend: Vaccines shake a leg to Rasputin | Oneindia News
Credit: Oneindia Duration: 01:06Published
Vaccines to last for 2 days, expect GoI to send them: Odisha COVID Vaccination In-Charge
Credit: ANI Duration: 01:35Published
Odisha: After vaccine shortage reports, long queues outside vaccination centre
Credit: HT Digital Content Duration: 03:35Published
Nurses share experience after administering COVID vaccine to PM Modi
Credit: ANI Duration: 01:16Published
PM Modi gets Covid-19 vaccine second dose, says 'if eligible, get your shot' | Oneindia News
Credit: Oneindia Duration: 01:11Published
Watch: PM Modi receives second dose of Covid vaccine; nurses share experience
Credit: HT Digital Content Duration: 02:24Published
PM Modi takes 2nd jab of COVID-19 vaccine at AIIMS
Credit: ANI Duration: 01:26Published
Covid: Delhi Dy CM gets first vaccine jab as capital faces infection surge
Credit: HT Digital Content Duration: 03:49Published
Covid: Centre explains 5 steps discussed with States to curb virus spread
Credit: HT Digital Content Duration: 09:52Published
Watch: Harsh Vardhan takes 2nd dose of Covaxin, says 7 more vaccines in trials
Credit: HT Digital Content Duration: 05:01Published
You Might Like
Covishield may protect against double mutant: CCMB reportA day after the Indian Council of Medical Research (ICMR) announced that Covaxin fights the so-called double mutant, B.1.617, the city-based Centre for Cellular and Molecular Biology (CCMB) said on..
Honest thieves 'return' coronavirus vaccine with apology in HaryanaAs per the police, the thieves took away 1,710 doses of Covishield and Covaxin from the storeroom of the Civil Hospital.
COVID-19: 1,710 doses of Covishield and Covaxin stolen from Jind civil hospitalA total of 1,270 doses of Covishield and 440 of Covaxin were stolen from the hospital, SHO of Civil Lines police station Rajender Singh said.
‘Covaxin efficacy 78%, works against variants’Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe Covid-19 disease, its developers Bharat..
COVID vaccine data: How many people tested positive after first and second dose?As per the data, more than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin.
Covaxin shows 78% overall interim efficacy, 100% efficacy against severe Covid: Bharat Biotech & ICMRBharat Biotech's Covaxin vaccine has shown 78% interim efficacy against the coronavirus, as per the result from phase 3 trials. The vaccine has also demonstrated 100% efficacy against severe Covid-19.
Covaxin neutralises double mutant strain, effective against multiple variants of SARS-CoV-2: ICMRBharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe.
Covaxin phase 3 trials show interim clinical efficacy of 78%
Covishield comprises over 90% of 12.76 crore Covid vaccines administered so farOf the 127,605,870 Covid-19 vaccination jabs administered till now, 11,60,65,107 are of Covishield while 1,15,40,763 are of Covaxin, according to the government's CO-WIN portal.
Covaxin effective against double mutant strain found in India: ICMR study
Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annumBharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Tuesday said it has scaled up its manufacturing capacities of Covaxin to 700 million doses per annum making it one of the..
Covaxin production to increase 10 times by September: Harsh Vardhan
Use entire national capacity to step up Covid vaccine production, PM tells officialsThe PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and distribution and the government..
Covaxin production to be increased to 100 million doses per month by September 2021: CentreUnion health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
Also reported by •IndiaTimes
Maharashtra gets nod to make Covaxin at Haffkine
Rajasthan: 320 doses of COVID-19 vaccine Covaxin go missing from Jaipur hospitalIn a first of its kind case in Rajasthan, as many as 32 vials of COVID-19 vaccine Covaxin containing 320 doses have gone missing from the Kanwatia Hospital in Jaipur. The hospital has registered a case..
‘Covaxin, Covishield both work against Covid's UK strain’Both Covaxin and Covishield — the two vaccines against Covid in use in India — are effective against the UK variant, which is one the two prevailing mutations found in the country, senior officials..
Vietnam envoy takes first dose of Indian COVID-19 vaccine CovaxinThe Vietnamese envoy joins other envoys in getting vaccinated. Earlier this month, Australian envoy got vaccinated using Covishield vaccine.
COVID-19 news: India gets third vaccine as Russia's Sputnik V gets nod for emergency useThis is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin.
PM Modi takes 2nd dose of Covid vaccine at AIIMS, DelhiPrime Minister Narendra Modi on Thursday took the second dose of the Covid-19 vaccine at the All India Institute of Medical Sciences (AIIMS) in New Delhi. The Prime Minister took his first dose of the..
Also reported by •DNA
PM Modi takes second dose of Covaxin
Covaxin gets nod for trial of booster shot
Covid-19: Government's expert panel allows clinical trials for third dose of CovaxinBharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose..
Why Brazil has denied permission to import Bharat Biotech's Covaxin
Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: GovtBoth Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre..
Govt raises gap between Covishield shots to 4-8 weeksThe health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed higher efficacy following a longer gap..
Second dose of Covishield vaccine to be administered in 6-8 weeks now instead of 4Notably, the new guidelines are only applicable to the Covishield vaccine and not the Covaxin coronavirus vaccine.
Increase gap between two doses of Covishield to 6-8 weeks, Centre tells statesThe Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8 weeks from the current 28 days.The Centre..
Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants, says government
Uddhav Thackrey to PM Modi: Allow Maharashtra firm to make Covaxin
Maharashtra government asks Centre to allow manufacture of Covaxin in state
In U-turn, C’garh mantri ready for Covaxin
Govt says move to use Covaxin now vindicated
Covaxin out of clinical trial mode, granted restricted emergency use authorisationThe Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular restricted emergency use authorisation just..
Covaxin works on Brazil, SA strains, initial findings show
Expert panel recommends dropping ‘clinical trial mode’ tag for CovaxinIn a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator's subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial..
CDSCO expert panel recommends Covaxin be moved out of 'clinical trial mode'An expert panel of India's central drugs authority on Wednesday recommended granting emergency use authorisation to Bharat Biotech's indigenously developed Covaxin while removing the condition for the..
Covaxin safe, induces immune response with no severe effects: LancetIn an encouraging development for India's vaccination drive, leading UK medical journal The Lancet on Tuesday said that indigenously developed Covaxin was found to be safe and has demonstrated better..
Lancet publishes Covaxin phase 2 trials dataprestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens between Phase 1 (two doses given 2 weeks..
Mexico experts recommend approving Indian vaccineA technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company Bharat Biotech. The report by the..
Govt sees Covaxin efficacy as validation of its scientific processThe phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and regulatory decision making while granting..
Zimbabwe first in Africa to OK Covaxin
Covaxin has 81% interim vaccine efficacy - here's what it meansThe trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
Covaxin shows 81% efficacy, say ICMR and Bharat BiotechThis interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical Research (ICMR), said in a statement. The..
Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 resultsCovaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech
3.4 lakh Covaxin vials lie unused in Karnataka
PM Modi takes the shot, gives vaccine process a booster doseThe PM, who is 70, was administered Covaxin, the indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). This decision too seemed deliberate..
DNA Special: PM Narendra Modi takes Covaxin jab but Opposition plays politics?Prime Minister Narendra Modi on Monday was administered the first dose of COVID-19 vaccine Covaxin at AIIMS, Delhi.
PM Modi sends out key message as he takes Covaxin shotPrime Minister Narendra Modi was administered the first dose of Covid-19 vaccine on Monday. Among the two vaccines available in India, PM Modi was administered the Bharat Biotech's Covaxin, developed..